Post by Tyra Biosciences

As the #BladderCancer treatment landscape continues to evolve, there remains a need for differentiated therapeutic approaches for people living with low-grade upper tract urothelial carcinoma (LG-#UTUC). Through our #SURF303 clinical trial, our team at Tyra Biosciences is evaluating a potential new treatment option designed to help address ongoing unmet needs for individuals affected by LG-UTUC. Learn more about the study: https://surf303.bio/ #TyraBiosciences